[1]
Gürkan, E. 2023. Effects of Dapagliflozin on Serum Low-Density Lipoprotein Cholesterol and Triglyceride Levels. European Journal of Therapeutics. 26, 1 (Apr. 2023), 76–80. DOI:https://doi.org/10.5152/eurjther.2020.19005.